Interaction Color Code
Clinical Bottom Line
Minimal data to guide interaction: weigh risks and benefits of using this combination
Drug 1
Drug 2
Drug 2 dose
4 mg BID
Clinical Effects
Increased tacrolimus effects (eg, bone marrow suppression)
Management
If coadministering consider initiating lower immunosuppressant dose to account for potential increased concentrations and monitor for toxicities. Therapeutic drug monitoring is recommended. Consult with specialist as necessary.
Import ID
1098
